Correlation Between Pasithea Therapeutics and ELYM Old
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and ELYM Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and ELYM Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and ELYM Old, you can compare the effects of market volatilities on Pasithea Therapeutics and ELYM Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of ELYM Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and ELYM Old.
Diversification Opportunities for Pasithea Therapeutics and ELYM Old
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pasithea and ELYM is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and ELYM Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ELYM Old and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with ELYM Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ELYM Old has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and ELYM Old go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and ELYM Old
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the ELYM Old. In addition to that, Pasithea Therapeutics is 1.01 times more volatile than ELYM Old. It trades about -0.02 of its total potential returns per unit of risk. ELYM Old is currently generating about 0.02 per unit of volatility. If you would invest 384.00 in ELYM Old on October 11, 2024 and sell it today you would lose (75.00) from holding ELYM Old or give up 19.53% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 95.75% |
Values | Daily Returns |
Pasithea Therapeutics Corp vs. ELYM Old
Performance |
Timeline |
Pasithea Therapeutics |
ELYM Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pasithea Therapeutics and ELYM Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pasithea Therapeutics and ELYM Old
The main advantage of trading using opposite Pasithea Therapeutics and ELYM Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, ELYM Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ELYM Old will offset losses from the drop in ELYM Old's long position.Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |